<DOC>
	<DOCNO>NCT02598934</DOCNO>
	<brief_summary>This study evaluate whether early positive response once-monthly oral ibandronate treatment-naive participant postmenopausal osteoporosis predictive efficacy later treatment . The anticipated time study treatment 6 month , target sample size 360 individual .</brief_summary>
	<brief_title>A Study Ibandronate ( Boniva ) Evaluate Bone Turnover Markers Women With Treatment-Naive Postmenopausal Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Women newly diagnose postmenopausal osteoporosis Naive prior bisphosphonate therapy Inability stand sit upright least 60 minute Inability swallow tablet whole Hypersensitivity component ibandronate Hormone ( estrogen ) replacement therapy within last 3 month , start therapy within next 6 month Other osteoporosis drug within last 3 month Malignant disease diagnose within previous 10 year , except resect basal cell cancer</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>